LFMD / LifeMD: A Derivative Beneficiary Of The Demand For Anti-Obesity Pharmaceuticals

LifeMD, Inc.'s share price is soaring, once again. The company's focus on GLP-1 medications integration and primary care services exemplifies its comm more_horizontal

LifeMD reached positive operating cash flow for the first time during its fiscal 2023 second quarter. This boosted the telehealth company's cash and e more_horizontal

Primarily, one reason stands above all the others regarding the incentive behind stocks with insider buying: those who are closest to a particular bus more_horizontal

LifeMD is positioned for rapid growth with the introduction of a weight management program and partnerships with Nutrisystem and Medifast. The company more_horizontal

LifeMD, Inc. (NASDAQ:LFMD ) Q2 2023 Earnings Call Transcript August 9, 2023 4:30 PM ET Company Participants Justin Schreiber - Chairman and Chief Exec more_horizontal

Shares of telehealth platform LifeMD, Inc. have cratered 85% from their all-time high of February 2021, as profitability had been elusive. That said, more_horizontal

LifeMD's year-to-date returns of 106% show a management turnaround, with the company aiming to reach cash flow breakeven by mid-2023. The telehealth m more_horizontal

AGF Management Ltd (NASDAQ:LFMD ) Q1 2023 Earnings Conference Call March 22, 2023 4:30 PM ET Company Participants Jenny Quinn - VP, CAO & Interim CFO more_horizontal